926 related articles for article (PubMed ID: 8791265)
1. Melanocortin probes for the melanoma MC1 receptor: synthesis, receptor binding and biological activity.
Erskine-Grout ME; Olivier GW; Lucas P; Sahm UG; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Melanoma Res; 1996 Apr; 6(2):89-94. PubMed ID: 8791265
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and receptor binding analysis of thirteen oligomeric alpha-MSH analogs.
Brandenburger Y; Rose K; Bagutti C; Eberle AN
J Recept Signal Transduct Res; 1999; 19(1-4):467-80. PubMed ID: 10071778
[TBL] [Abstract][Full Text] [Related]
3. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
4. Receptors for melanocyte-stimulating hormone on melanoma cells.
Eberle AN; Siegrist W; Bagutti C; Chluba-De Tapia J; Solca F; Wikberg JE; Chhajlani V
Ann N Y Acad Sci; 1993 May; 680():320-41. PubMed ID: 8390156
[No Abstract] [Full Text] [Related]
5. The melanocyte-stimulating hormone (MSH) receptor in M2R mouse melanoma tumours: solubilization and properties of the receptor-MSH complex and its covalently crosslinked conjugate.
Shafir I; Schmidt-Sole J; Shai E; Salomon Y
Melanoma Res; 1993 Jun; 3(3):157-68. PubMed ID: 8400853
[TBL] [Abstract][Full Text] [Related]
6. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
7. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.
Wong W; Minchin RF
Int J Biochem Cell Biol; 1996 Nov; 28(11):1223-32. PubMed ID: 9022281
[TBL] [Abstract][Full Text] [Related]
8. Receptor binding affinities and biological activities of linear and cyclic melanocortins in B16 murine melanoma cells expressing the native MC1 receptor.
Sahm UG; Olivier GW; Branch SK; Moss SH; Pouton CW
J Pharm Pharmacol; 1996 Feb; 48(2):197-200. PubMed ID: 8935171
[TBL] [Abstract][Full Text] [Related]
9. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the internalization of [125I-Tyr2, Nle4, D-Phe7] alpha-MSH following binding to the MSH receptor of B16 murine melanoma cells.
Adams G; Olivier GW; Branch SK; Moss SH; Notarianni LJ; Pouton CW
Ann N Y Acad Sci; 1993 May; 680():440-1. PubMed ID: 8390163
[No Abstract] [Full Text] [Related]
11. Synthesis and biological evaluation of alpha-MSH analogues substituted with alanine.
Sahm UG; Olivier GW; Branch SK; Moss SH; Pouton CW
Peptides; 1994; 15(7):1297-302. PubMed ID: 7854984
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue.
Vaidyanathan G; Zalutsky MR
Nucl Med Biol; 1997 Feb; 24(2):171-8. PubMed ID: 9089709
[TBL] [Abstract][Full Text] [Related]
13. Dimeric DOTA-alpha-melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activity.
Bapst JP; Froidevaux S; Calame M; Tanner H; Eberle AN
J Recept Signal Transduct Res; 2007; 27(5-6):383-409. PubMed ID: 18097939
[TBL] [Abstract][Full Text] [Related]
14. Use of an alpha-melanocyte-stimulating hormone analogue to improve alpha-melanocyte-stimulating hormone receptor binding assay in human melanoma.
Libert A; Ghanem G; Arnould R; Lejeune FJ
Pigment Cell Res; 1989; 2(6):510-8. PubMed ID: 2557606
[TBL] [Abstract][Full Text] [Related]
15. Influence of alpha-MSH terminal amino acids on binding affinity and biological activity in melanoma cells.
Sahm UG; Olivier GW; Branch SK; Moss SH; Pouton CW
Peptides; 1994; 15(3):441-6. PubMed ID: 7937316
[TBL] [Abstract][Full Text] [Related]
16. Antagonist and agonist activities of the mouse agouti protein fragment (91-131) at the melanocortin-1 receptor.
Eberle AN; Bódi J; Orosz G; Süli-Vargha H; Jäggin V; Zumsteg U
J Recept Signal Transduct Res; 2001 Feb; 21(1):25-45. PubMed ID: 11693171
[TBL] [Abstract][Full Text] [Related]
17. Photoaffinity labelling of melanoma cell MSH receptors.
Scimonelli T; Eberle AN
FEBS Lett; 1987 Dec; 226(1):134-8. PubMed ID: 3691812
[TBL] [Abstract][Full Text] [Related]
18. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
[TBL] [Abstract][Full Text] [Related]
20. Agouti antagonism of melanocortin binding and action in the B16F10 murine melanoma cell line.
Blanchard SG; Harris CO; Ittoop OR; Nichols JS; Parks DJ; Truesdale AT; Wilkison WO
Biochemistry; 1995 Aug; 34(33):10406-11. PubMed ID: 7544613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
